Over the past two decades, huge advancements in sequencing technology have transformed our understanding of human genetics, leading to faster diagnoses, earlier prevention, and better treatments. But as more and more people have their genomes sequenced, outpacing our ability to analyze and interpret the generated data, we must embrace new tools, technologies, and strategies to realize the full value of genomic innovation.

You’re invited to take a seat at the forefront of germline analytics, as part of the Hereditary NGS Clinical Summit Series, a two-part, free-to-attend virtual event for variant scientists, bioinformaticians, clinical geneticists, and lab managers. 

Part I: Thursday, October 13, 2022 

An informative scientific and clinical segment focusing on how to streamline and scale components of the NGS analytical workflow.

Attendees will learn:

  • How to simplify NGS secondary analysis workflows to 5 steps
  • How to solve every hereditary disorder case for all types of mutations
  • How to address current challenges in germline and exome analytics 

Part II: Thursday, November 10, 2022

An expert panel of leading medical geneticists, variant scientists and bioinformaticians will discuss emerging scientific and clinical trends in germline NGS testing.

Attendees will gain:

  • Insight into how leading laboratories address bottlenecks in their NGS data pipelines
  • Tips on how to solve process inefficiencies of critical workflow components, including variant curation and interpreting rare or novel variants
  • An outlook on how germline NGS analysis and interpretation will change in the next 5 years and how to remain at the forefront of innovation

Plus, all attendees receive a complimentary trial of HGMD Professional, the largest, manually curated resource for finding disease-causing mutations, and complimentary demonstrations of QCI Secondary Analysis and QCI Interpret, NGS variant analysis, interpretation and reporting software.

About the speaker
Neha Jalan, Ph.D., Professional Services Solution Manager
QIAGEN Digital Insights
Georgios Stamoulis, Director of Global Product Management
QIAGEN Digital Insights
Georgios Stamoulis holds the position of QIAGEN Digital Insights Director of Global Product Management for Hereditary diseases. Dr. Georgios Stamoulis is a Molecular Geneticist by training and he holds a PhD in Human Genetics from the University of Geneva, and an MSc in Medical Genetics from university of Glasgow. Georgios has more than 12 years of experience in human genetics and genomic diagnostics & research and in product management of hereditary disease products with a focus on NGS interpretation tools. Before joining QIAGEN, Georgios served as the Global Product Manager of Hereditary diseases in SOPHiA Genetics. In 2016, he received the “Fellowship of Excellence for Young Investigators” from the European Society of Human Genetics (ESHG). He is also an author of multiple human genomics publications.
Malaina Gaddis, Ph.D., Clinical Field Application Scientist
QIAGEN Digital Insights
Dr. Malaina Gaddis is a Clinical Field Application Scientist at QIAGEN Digital Insights. Prior to joining the QIAGEN team, Dr. Gaddis gained her clinical diagnostics industry experience as a Genome Variant Scientist at Progenity and at CopperGenomics, while working on carrier screening products for rare-inherited diseases.Dr. Gaddis earned her Ph.D. from the University of Southern California and was a post-doctoral fellow in Bioscience Management at Keck Graduate Institute.
Date of recording:Thursday, 13 October 2022
Duration:120 minutes
Human Genetics
Informatics & Data